Connor Clark & Lunn Investment Management Ltd. Trims Stake in IonQ, Inc. $IONQ

Connor Clark & Lunn Investment Management Ltd. lessened its stake in shares of IonQ, Inc. (NYSE:IONQ) by 28.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 602,183 shares of the company’s stock after selling 235,726 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s holdings in IonQ were worth $37,034,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of IONQ. BNP Paribas Financial Markets raised its holdings in shares of IonQ by 21.8% in the third quarter. BNP Paribas Financial Markets now owns 298,967 shares of the company’s stock worth $18,386,000 after acquiring an additional 53,504 shares during the last quarter. Mackenzie Financial Corp boosted its stake in shares of IonQ by 127.5% during the third quarter. Mackenzie Financial Corp now owns 19,661 shares of the company’s stock valued at $1,209,000 after acquiring an additional 11,019 shares during the last quarter. Franklin Resources Inc. boosted its stake in shares of IonQ by 644.6% during the third quarter. Franklin Resources Inc. now owns 970,386 shares of the company’s stock valued at $59,679,000 after acquiring an additional 840,061 shares during the last quarter. Van ECK Associates Corp increased its position in IonQ by 298.6% during the 3rd quarter. Van ECK Associates Corp now owns 364,428 shares of the company’s stock worth $22,412,000 after purchasing an additional 273,010 shares in the last quarter. Finally, Legal & General Group Plc increased its position in IonQ by 21.8% during the 3rd quarter. Legal & General Group Plc now owns 917,246 shares of the company’s stock worth $56,411,000 after purchasing an additional 163,972 shares in the last quarter. Hedge funds and other institutional investors own 41.42% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. Rosenblatt Securities restated a “buy” rating and issued a $100.00 target price on shares of IonQ in a report on Thursday, February 26th. Cantor Fitzgerald reiterated an “overweight” rating on shares of IonQ in a report on Monday, February 9th. Needham & Company LLC cut their price objective on shares of IonQ from $80.00 to $65.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Morgan Stanley set a $37.00 price objective on shares of IonQ in a research note on Thursday, February 26th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of IonQ in a research report on Thursday, January 22nd. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $69.45.

IonQ Trading Down 3.5%

Shares of NYSE:IONQ opened at $33.06 on Friday. The firm has a market cap of $12.12 billion, a price-to-earnings ratio of -13.28 and a beta of 2.61. The stock’s 50-day moving average price is $40.41 and its two-hundred day moving average price is $50.05. IonQ, Inc. has a 12-month low of $18.81 and a 12-month high of $84.64.

IonQ News Summary

Here are the key news stories impacting IonQ this week:

• Positive Sentiment: Landmark University of Cambridge collaboration to establish the IonQ Quantum Innovation Centre to commercialize quantum research, expand IP and deploy advanced systems — strengthens IonQ’s academic/commercial pipeline and UK presence. Read More.
• Positive Sentiment: Planned deployment of a 256‑qubit system into the Cambridge research ecosystem signals product progress and makes IonQ’s hardware roadmap more tangible for researchers and customers. Read More.
• Positive Sentiment: Deepening federal / security work (ARLIS collaboration on quantum Zero Trust architecture) increases IonQ’s relevance for government contracts and secure-use cases. Read More.
• Positive Sentiment: Bullish media/analyst commentary argues IonQ’s cost and performance advantages could drive faster growth and mean the company may outperform longer term — supportive sentiment for investors focused on fundamentals. Read More.
• Neutral Sentiment: Management presentation/transcript from the 2026 Cantor Global Technology & Industrial Growth Conference is available for investors looking for updated strategy, KPIs and product roadmaps. Read More.
• Neutral Sentiment: General market roundups have included IonQ among names moving recently; useful for monitoring short-term volatility but not a direct catalyst. Read More.
• Negative Sentiment: IonQ filed a prospectus supplement enabling the resale of more than 2.5 million common shares by a major stockholder — this creates potential near-term share-supply pressure and likely contributed to intraday selling. Read More.
• Negative Sentiment: Coverage notes the stock has fallen more steeply than the broader market in the recent tech sell-off (cited ~25.6% YTD underperformance), reflecting macro tech spending uncertainty that can delay enterprise quantum adoption. Read More.

Insider Transactions at IonQ

In related news, insider Robert T. Cardillo sold 5,165 shares of the firm’s stock in a transaction that occurred on Thursday, February 26th. The shares were sold at an average price of $39.44, for a total value of $203,707.60. Following the sale, the insider directly owned 112,291 shares of the company’s stock, valued at approximately $4,428,757.04. This trade represents a 4.40% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Kathryn K. Chou sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, December 22nd. The shares were sold at an average price of $55.00, for a total transaction of $275,000.00. Following the completion of the sale, the director owned 60,839 shares of the company’s stock, valued at approximately $3,346,145. The trade was a 7.59% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 10,781 shares of company stock worth $497,804 in the last three months. Company insiders own 5.20% of the company’s stock.

IonQ Company Profile

IonQ, Inc engages in the development of general-purpose quantum computing systems in the United States. It sells access to quantum computers of various qubit capacities. The company makes access to its quantum computers through cloud platforms, such as Amazon Web Services (AWS) Amazon Braket, Microsoft’s Azure Quantum, and Google’s Cloud Marketplace, as well as through its cloud service. It also provides contracts associated with the design, development, and construction of specialized quantum computing hardware systems; maintenance and support services; and consulting services related to co-developing algorithms on quantum computing systems.